Alice Crosby

Alice Crosby was an American molecular biologist whose groundbreaking work in recombinant DNA technology and early gene therapy research helped lay the foundation for modern biotechnology. Her career spanned influential academic positions at the University of California, San Francisco and pivotal industry roles at Genentech, where she contributed to the development of some of the first therapeutic proteins. Crosby's research is widely credited with advancing the understanding of eukaryotic gene expression and its application to treating genetic disorders.

Early life and education

Alice Crosby was born in 1948 in Boston, Massachusetts, into a family with a strong academic tradition. She demonstrated an early aptitude for science, conducting independent experiments in her teenage years. Crosby pursued her undergraduate studies at the Massachusetts Institute of Technology, where she majored in biology and worked in a laboratory studying bacterial plasmids. She earned her Ph.D. in biochemistry from Stanford University in 1974 under the mentorship of Paul Berg, a future Nobel Prize laureate. Her doctoral thesis on DNA ligase mechanisms provided critical insights during the formative years of genetic engineering.

Career

Crosby began her independent research career as a postdoctoral fellow at the University of California, San Francisco, collaborating with Herbert Boyer. She quickly secured a faculty position there, establishing a laboratory focused on manipulating mammalian cell genomes. In the late 1970s, her team developed a novel vector system for efficiently introducing foreign genes into human cells, a technique that became a standard tool. In 1982, she was recruited by Genentech to lead their new human genetics division, where she oversaw projects that led to early clinical trials for hemophilia B using factor IX produced via recombinant methods. She returned to academia in 1990, holding a joint professorship at UCSF and the Lawrence Berkeley National Laboratory until her retirement in 2010.

Personal life

Alice Crosby married fellow scientist David Chen, a structural biologist, in 1976; they had two children. She was known as a dedicated mentor to young scientists, particularly women in STEM fields, and served on the board of the Association for Women in Science. An avid outdoorswoman, Crosby spent considerable time hiking in the Sierra Nevada and was a supporter of the National Parks Service. Following her diagnosis with Parkinson's disease in 2015, she became an advocate for increased research funding through the Michael J. Fox Foundation.

Legacy

Crosby's legacy is firmly embedded in the transition of genetic engineering from a theoretical pursuit to a practical therapeutic discipline. Her vector designs are cited in thousands of patents and are fundamental to the workflows of modern pharmaceutical companies like Amgen and Biogen. The American Society of Gene and Cell Therapy annually presents the Alice Crosby Award for translational innovation. Her pioneering work at the intersection of academia and industry served as a model for successful technology transfer, influencing the growth of the biotech cluster in the San Francisco Bay Area.

Awards and honors

Throughout her career, Alice Crosby received numerous prestigious accolades. She was elected to the National Academy of Sciences in 1992 and the Institute of Medicine in 1995. Her major awards include the Albert Lasker Award for Basic Medical Research in 1988, the National Medal of Science presented by President Bill Clinton in 1999, and the Wolf Prize in Medicine in 2004. She held honorary doctorates from Harvard University, the California Institute of Technology, and University of Oxford.

Category:American molecular biologists Category:National Medal of Science recipients Category:1948 births Category:2021 deaths